English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52190196    線上人數 :  950
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"wen sheng tzeng"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-8 / 8 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
義守大學 2015-09 Do ePortfolios Contribute to Learners’ Reflective Thinking Activities? : A Preliminary Study of Nursing Staff Users Wen-Sheng Tzeng;Kuang-Ming Kuo;Paul C. Talley;Hsiu-Chin Chen;Jhi-Joung Wang
義守大學 2013-09 A Socio-technical assessment of the success of picture archiving and communication systems: the radiology technologist’s perspective Wen-Sheng Tzeng;Kuang-Ming Kuo;Huang-Wei Lin;Tai-Yuan Chen
義守大學 2012-11 A comparison of pyelography and various reconstructions of multidetector helical computed tomography urography images for diagnosing urinary obstruction Wen-Sheng Tzeng;Reng-Hong Wu;Steven Kuan-Hua Huang;Chee-Wai Mak;Alex Chien-Hwa Liao;Victor Chia-Hsiang Lin
義守大學 2012-11 Imaging features of posterior limbus vertebrae Pei-Yu Huang;Lee-Ren Yeh;Wen-Sheng Tzeng;Meng-Yuan Tsai;Tiffany Ting-Fang Shih;Huay-Ben Pan;Clement Kuen-Huang Chen
嘉南藥理大學 2007-04 Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-κB signaling pathway. Po-Lin Kuo; Ya-Ling Hsu; Ta-Chen Lin; Wen-Sheng Tzeng; Yin-Yi Chen; Chun-Ching Lin
高雄醫學大學 2007 Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-κB signaling pathway.  郭柏麟;許雅玲;林大楨;曾文盛;陳怡瑩;林俊清  ; Po-Lin Kuo;Ya-Ling Hsu;Ta-Chen Lin;Wen-Sheng Tzeng;Yin-Yi Chen;Chun-Ching Lin  
義守大學 2006-06 Percutaneous Wallstent Implantation to Rescue Failed Ureteropyelostomy for Massive Ureteral Necrosis after Renal Transplantation Victor Chia-Hsiang Lin;Alex Chien-Hwa Liao;Li-Ching Chang;Wen-Sheng Tzeng
南台科技大學 2006-02 癌症登記即時統計分析系統之建立 洪景男; Ching-Nan Hung; 曾文盛; Wen-Sheng Tzeng; 陳培展; Pei-Jarn Chen; 陳彥廷; Yen-Ting Chen

顯示項目 1-8 / 8 (共1頁)
1 
每頁顯示[10|25|50]項目